Effectiveness And Cost Per Responder With First-Line Biologics For Rheumatoid Arthritis Using A Validated, Claims-Based Algorithm In A Large Us Commercial Health Plan
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1132
https://www.valueinhealthjournal.com/article/S1098-3015(13)01203-5/fulltext
Title :
Effectiveness And Cost Per Responder With First-Line Biologics For Rheumatoid Arthritis Using A Validated, Claims-Based Algorithm In A Large Us Commercial Health Plan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01203-5&doi=10.1016/j.jval.2013.03.1132
First page :
A223
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
706